Investigating tissue factor pathway inhibitor and other protease and protease inhibitors and their association with major adverse aortic events in patients with abdominal aortic aneurysm
These findings suggest that TFPI may serve as a valuable prognostic marker for the risk of MAAEs within 5 years in patients with AAA, potentially offering new tools for the medical management of patients with AAA.
Authors
- Mohammad Qadura (ORCID: https://orcid.org/0000-0003-0893-9920)
- Hamzah Khan (ORCID: https://orcid.org/0000-0001-5252-3370)
- Muhammad Mamdani (ORCID: https://orcid.org/0000-0001-5199-6344)
- Gustavo Saposnik (ORCID: https://orcid.org/0000-0002-5950-9886)
- Abdelrahman Zamzam (ORCID: https://orcid.org/0000-0003-3291-5902)
- Farah Shaikh
Institutions
- St. Michael's Hospital (CA)
- University of Toronto (CA)
- Technology Innovation Institute (AE)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2024-11-28
- DOI
- https://doi.org/10.1016/j.rpth.2024.102645
- Citations
- 2
- Primary Topic
- Aortic aneurysm repair treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.84